Track topics on Twitter Track topics that are important to you
Delivering more than two decades of implant innovation to over 60,000 people, Cochlear is built upon a foundation of success.
How did we get there? In a word: Goals. By setting corporate goals for customer focus, organisational performance, and shareholder value, strategic thinking has leveraged our innovation into a very successful business. Our goals include:
We focus on bringing customers lifetime value with:
Innovative, high-quality products and services that help implant recipients interact more fully with their world.
A continuous service-oriented experience from start to finish. Every customer interaction and experience is seamless, consistent and positive.
Customer information systems that deliver products and services to match customer preferences and needs.
Ours is a dynamic, performance-focused organization, poised to achieve its full potential with:
A corporate culture and core values that attract and retain high-quality talent.
Leadership capabilities that ensure a lasting, compelling future for employees.
Tools and processes for managing performance.
400 Inverness ParkwaySuite 400
United States of America
Phone: 1 303 790 9010
Fax: 1 303 792 9025
Australian medical device provider Cochlear has unveiled a new cochlear implant sound processor dubbed as Cochlear Nucleus 7 Sound Processor, made exclusively for iPhone.
Cochlear implants that have electrodes designed without wire perform better than those with wires for long-term hearing preservation, a Mount Sinai researcher has reported in a first-of-its-kind study...
Life Sciences Jobs ...
Cochlear, an Australian medical device company that makes cochlear implants to treat hearing loss, announced plans to build a $38.6 million manufacturing facility in Chengdu, China. Cochlear said it n...
New research findings could transform treatment for people with cochlear implants worldwide, and may also enhance patient care.
FDA approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform.
Clinical Informatics News Brief The U.S. Food and Drug Administration today approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicin...
The collaboration with Cochlear Ltd. is an example of how Apple has been ramping up its medtech profile.
Minorities often lag behind in hearing loss evaluation and treatment. Our cochlear implant program aimed to identify the socioeconomic and cultural barriers that prevented our African-American cochlea...
The clinical effects of bilateral cochlear implantation (BCI) include binaural summation and better hearing under noise conditions. This study retrospectively examined the utility of BCI compared to u...
Cochlear fistula in the chronic otitis media (COM) without cholesteatoma is an extremely rare with only a few cases reported in the literature to this date. We describe a case of cochlear fistula obse...
Cochlear implant research and product development over the past 40 years have been heavily focused on speech comprehension with little emphasis on music listening and enjoyment. The relatively little ...
To compare imaging and outcome data in cochlear implant (CI) patients with and without cochlear nerve deficiency (CND).
The purpose of this study is to evaluate and document longitudinal efficacy in young children implanted bilaterally with MED-EL COMBI 40+ / PULSARCI100/SONATATI100 cochlear implant systems...
The purpose of this study is to evaluate short and long term outcomes (benefits and side-effects) of bilateral cochlear implantation in Finnish children.
The purpose of this study is to show that cochlear implant treatment improves the overall health related quality of life and general well-being in elderly individuals.
Cochlear implants require programming on an individual basis to provide appropriate levels of electrical stimulation. This program, or "map", is placed in the speech processor of the cochl...
Cochlear implants are surgically implanted devices which restore the ability to hear to the hearing impaired. While remarkably successful, even in the best of performers restoration of hea...
Cochlear implants are a proven medical option for children as young as 12 months old with profound hearing loss in both ears and for individuals who are two years or older with severe to profound hear...
AB is a global leader in developing one of the most advanced cochlear implant systems in the world. Founded in 1993 and partnered with Phonak under the Sonova Group in 2009, AB de...
Advanced Bionics is a global leader in developing the most advanced cochlear implant systems in the world. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB deve...
MED-EL Medical Electronics is a leading provider of hearing implant systems worldwide. The company was founded by Austrian scientists and industry pioneers Ingeborg and Erwin Hoch...
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...
We have published hundreds of Cochlear Corporation news stories on BioPortfolio along with dozens of Cochlear Corporation Clinical Trials and PubMed Articles about Cochlear Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cochlear Corporation Companies in our database. You can also find out about relevant Cochlear Corporation Drugs and Medications on this site too.